Atlas Trials

Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT05061901 · COMPLETED

Trial details

NCT number
NCT05061901
Sponsor
Pharmtechnology LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2021-10-06
Primary completion
2021-11-06
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.